Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr.

Similar presentations


Presentation on theme: "Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr."— Presentation transcript:

1 Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr Elnashar, M.D., Mohamed El-Ashry, M.D., May Shahat, M.D.  Fertility and Sterility  Volume 91, Issue 3, Pages (March 2009) DOI: /j.fertnstert Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Hormonal changes during the course of GnRHa/chemotherapy cotreatment. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr."

Similar presentations


Ads by Google